CClinicalTrials.gg
CompletedNCT00711711Updated Jan 18, 2019Results posted

Manual Lymphatic Drainage Following Total Knee Arthroplasty Surgery

An interventional study of Manual lymphatic drainage and relaxation in Knee Arthroplasty, Total, sponsored by Haute Ecole de Santé Vaud. Completed at 2 sites in Switzerland. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2019-01-18.

Sponsored by Haute Ecole de Santé Vaud · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the efficiency of manual lymphatic drainage to decrease the swelling of the knee after total knee replacement surgery

Read the detailed description

Background There is scientific evidence that rehabilitation has a positive influence on patients'recovery after total knee arthroplasty (TKA). According to the literature, conventional rehabilitation aims to improve knee range of motion, lower limb strength, gait, activities and pain. Although swelling is a systematic consequence of TKA surgery, less focus is put on swelling reduction. Patients develop swelling due to periarticular edema, hematoma and joint effusion. Inflammation, pain, stiffness, alteration of gait pattern, quadriceps contraction inhibition and slowing of rehabilitation are reported as consequences of swelling. Accordingly, it is likely that a therapy that would promote resorption of swelling would decrease the negative impact of swelling on patients'recovery. Manual lymph drainage (MLD) could possibly accelerate edema resorption after TKA surgery. Several authors advise MLD after TKA, and physiotherapists currently apply MLD to reduce postsurgical swelling. Its positive effect on chronic lymphedema resorption is largely accepted. Results on pain and range of motion seem interesting from an empirical point of view but, to our knowledge, no scientifically driven studies have confirmed these positive effects after orthopaedic surgery.

Aim This study aims to evaluate the effect of MLD on swelling, and parameters possibly influenced by swelling (pain, knee range of motion, knee objective and subjective function and gait pattern).

Methods This study is a randomized controlled clinical trial. Patients will be blinded from goals of the treatments and evaluators will be blinded from the treatment delivered to the patient. The effects of MLD (5 treatments of 30 minutes from the second to the eighth postsurgical day) will be compared to those of a placebo (relaxation sessions). MLD or placebo will be added to the conventional rehabilitation program of our Orthopaedic Department. Assessments will be conducted one day before surgery, two days, 8 days and 3 months after surgery. Evolution and differences between groups will be statistically assessed at each step.

Significance This project aims to improve knowledge on the efficiency of rehabilitation treatments following TKA. It will contribute to effective evaluation of the effects of a widely applied treatment. The results will help physiotherapists and medical doctors to take clinical decisions based on documented evidence. This will make a contribution to better quality of care and better allocation of resources to rehabilitation.

02

Conditions studied

  • Knee Arthroplasty, Total

Keywords

  • Physical Therapy - Therapeutics - Edema
  • Arthroplasty replacement knee
  • Treatment outcome
03

In context

Lead sponsor

Haute Ecole de Santé Vaud is the lead sponsor of 17 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • knee replacement surgery

Exclusion criteria

Exclusion Criteria:

  • pacemaker
  • cardiac defibrillator
  • pathology of the lymphatic system
  • lower limb impairment which interferes with gait
  • neurological disease
  • unability to understand patient information letter or to give informed consent
  • unability to understand and complete questionnaires in French
  • contraindication to manual lymphatic drainage : thrombosis, infection, right cardiac insufficiency, active cancer
  • non standard knee replacement surgery
  • high dose anticoagulation
  • post surgical complication
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Manual lymphatic drainage

    this arm will receive 5 manual lymphatic drainage treatments from day 2 to day 7 post surgery

    Other: Manual lymphatic drainage

  • Placebo comparator
    Relaxation

    This arm will receive 5 relaxation treatments from day 2 to day 7 post surgery

    Other: relaxation

Interventions

  • OtherManual lymphatic drainage

    Each patient will receive 5 treatments of 30 minutes by a trained physiotherapist, from day 2 to day 7 post surgery

    Also known as: lymphatic drainage, manual lymph drainage, MLD

  • Otherrelaxation

    Each patient will receive 5 treatments of 30 minutes of tape recorded relaxation , from day 2 to day 7 post surgery

    Also known as: eriksonian hypnosis

06

What researchers measure

Primary outcomes

  1. Bioimpedance Percentage Difference Healthy/Operated

    The bioimpedance, i.e. a measurement in ohms of the opposition to current flow between electrodes was evaluated for each limb. Then the bioimpedance percentage difference between operated and healthy limb was calculated.

    Time frame: presurgery, 2 days, 7 days and 3 months post surgery

  2. Lower Limb Volume Percentage Difference Operated/Healthy

    The limb volume was evaluated for each limb using circumferential tape measurements at 4 cm intervals. Then the tape measurementy were converted into limb volume using the validated truncated-cone method, and the percentage difference between the operated and the healthy limb was calculated.

    Time frame: presurgery, and 2 days, 7 days and 3 months after surgery

07

Results

Posted Jan 18, 2019

Participant flow

Patients from the Department of Orthopedic and Traumatic Surgery of the University Hospital of Lausanne were recruited from July 1, 2008 to November 16, 2010

Participant flow — Overall Study
MilestoneManual Lymphatic DrainageRelaxation
Started3030
Second postsurgical day3030
Seventh postsurgical day2927
Completed2924
Not completed16

Outcome measures

PrimaryBioimpedance Percentage Difference Healthy/Operated

The bioimpedance, i.e. a measurement in ohms of the opposition to current flow between electrodes was evaluated for each limb. Then the bioimpedance percentage difference between operated and healthy limb was calculated.

Time frame:
presurgery, 2 days, 7 days and 3 months post surgery
Reported as:
Mean · percentage difference between limbs
Bioimpedance Percentage Difference Healthy/Operated
percentage difference between limbsPlaceboManual Lymphatic Drainage
Baseline limb bioimpedance R0 difference (%)1.8 ± 5.00.2 ± 4.5
Limb bioimpedance R0 difference at day 2 (%)12.9 ± 9.713.7 ± 72
Limb bioimpedance R0 difference at day 7 (%)41.8 ± 6.540.8 ± 6.6
Limb bioimpedance R0 difference at 3 months (%)16.6 ± 9.319.1 ± 11.0
Statistical analysis
  • Placebo vs Manual Lymphatic Drainage · Wilcoxon (Mann-Whitney) · p = 0.51
PrimaryLower Limb Volume Percentage Difference Operated/Healthy

The limb volume was evaluated for each limb using circumferential tape measurements at 4 cm intervals. Then the tape measurementy were converted into limb volume using the validated truncated-cone method, and the percentage difference between the operated and the healthy limb was calculated.

Time frame:
presurgery, and 2 days, 7 days and 3 months after surgery
Reported as:
Mean · percentage difference between limbs
Lower Limb Volume Percentage Difference Operated/Healthy
percentage difference between limbsManual Lymphatic DrainageRelaxation
Baseline limb volume difference (%)1.8 ± 5.00. ± 4.5
Limb volume difference at day 2 (%)12.9 ± 9.713.7 ± 7.2
Limb volume difference at day 7 (%)17.0 ± 10.715.3 ± 6.5
Limb volume difference at 3 months (%)3.7 ± 5.74.1 ± 5.1
Statistical analysis
  • Manual Lymphatic Drainage vs Relaxation · Wilcoxon (Mann-Whitney) · p = 0.58

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Manual Lymphatic Drainage0/30 (0%)0/30 (0%)0/30 (0%)
Relaxation0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Manual Lymphatic DrainageRelaxationTotal
<=18 years000
Between 18 and 65 years232144
>=65 years7916
Age, Continuous
Age, Continuous(years)Manual Lymphatic DrainageRelaxationTotal
Mean71.3 ± 8.570.1 ± 9.170.7 ± 8.8
Sex: Female, Male
Sex: Female, Male(Participants)Manual Lymphatic DrainageRelaxationTotal
Female182139
Male12921
Region of Enrollment
Region of Enrollment(participants)Manual Lymphatic DrainageRelaxationTotal
Switzerland303060
08

Study locations

2 sites
  • Département de l'Appareil Locomoteur - CHUV
    Lausanne, 1005, Switzerland
  • Haute Ecole Cantonale Vaudoise de Santé
    Lausanne, 1011, Switzerland
09

References and documents

Publications

  • Pichonnaz C, Bassin JP, Lecureux E, Christe G, Currat D, Aminian K, Jolles BM. Effect of Manual Lymphatic Drainage After Total Knee Arthroplasty: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2016 May;97(5):674-82. doi: 10.1016/j.apmr.2016.01.006. Epub 2016 Jan 30. PubMed 26829760 ↗

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00711711
Lead sponsor
Haute Ecole de Santé Vaud
Collaborators
University of Applied Sciences of Western Switzerland, University of Lausanne Hospitals
Responsible party
Claude Pichonnaz (Associate professor, Haute Ecole de Santé Vaud) — Principal investigator
First posted
Jul 9, 2008
Start date
Jun 2008
Primary completion
Jan 2011
Completion
Mar 2011
Results posted
Jan 18, 2019
Last update
Jan 18, 2019

Study contacts

Claude Pichonnaz, physiother
principal investigator · Haute Ecole Cantonale Vaudoise de Santé + Département de l'Appareil Locomoteur - CHUV
Brigitte M Jolles, PD MER MSc
study director · Département de l'Appareil Locomoteur - CHUV + Faculté des sciences et techniques de l'ingénieur (STI) - EPFL

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion